Loading...

AARTIPHARM Aarti Pharmalabs Ltd Legal Disputes Announcement

rt P

RTPH

Aarti Pharmalabs Ltd

(AARTIPHARM)

2026 Announcement

US FDA inspection

US FDA Inspection

Trading Window Closure

Chemical leak incident

Earnings Call Transcript

Regulatory clarification

Newspaper Publication

Earnings Call Outcome

Dividend record date correc...

Investor Presentation

Record date and interim div...

Interim Dividend Declaration

Interim dividend declaration

Interim Dividend Declaration

Earnings Conference Call

Board Meeting Intimation

Trading volume clarification

Regulatory Compliance

Appointment of Senior Manag...

Trading Window Closure

Earnings Call Transcript

Audio recording uploaded

Newspaper Publication

Investor Presentation

Financial Results

Financial Results

Financial Results Update

Management Changes

Earnings Call Announcement

Board Meeting Notice

Equity Shares Allotted

Injunction Order

Compliance Certificate

Investor Presentation

Management Change

100 Days Campaign

Investor Meet Scheduled

New Facility Inaugurated

Annual Report Dispatch

100 Days Campaign

AGM Announcement

Q1 FY26 Earnings

Financial Results Published

Earnings Call Recording

Q1 FY26 Results

Management Change

Secretarial Auditor Appoint...

Earnings Conference Call

Credit Rating Upgrade

Compliance Certificate

Investor Meet Scheduled

Compliance Report

Earnings Call Transcript

Earnings Call Recording

Financial Results Publication

Q4 FY25 Presentation

Stock Options Granted

Earnings Conference Call

EcoVadis Gold Rating

RTA Contact Update

Sustainability Milestone

Compliance Certificate

Joint Venture Established

Earnings Call Transcript

Earnings Call Recording

Financial Results Publication

Investor Presentation

Earnings Conference Call

Plant Re-Opening

Compliance Certificate

Equity Stake Acquisition

Vapi Plant Closure

New Compliance Officer

Earnings Call Transcript

Financial Results Publication

Earnings Call Recording

Management Change

Q2/H1 FY25 Results

Earnings Call Scheduled

Compliance Certificate

Directorate Change

Investor Presentation

Financial Results Publication

Earnings Announcement

Results Presentation

Earnings Conference Call

Publication Advertisement

AGM Announcement

Clarification on Closure of...

Certificate Submission

Credit Rating Announcement

Manufacturing Plant Closure

Compliance Report Submission

Financial Results Publication

Results Presentation

Appointment of Board Member...

Appointment of Directors an...

Board Meeting Outcome

Stock Option Grant

Earnings Call Scheduled

Certificate Submission

Regulatory Compliance

Compliance Certificate

Publication of Financial Re...

Earnings Conference Call

Results Presentation

Earnings Conference Call

Certificate Submission

Grant of Stock Options

Earnings Call Transcript

Conference Call Recording

Financial Results Publication

Conference Call

Certificate Submission

Investor Presentation

Financial Statements, Earni...

Financial Statements

Financial Statements

Conference Call Recording

Financial Statements

Earnings Releases

Financial Statements

Financial Statements

Analyst Presentation

Merger of Equals

Related Party Transactions ...

Financial Results Publication

Related Party Transactions ...

External Links:

Data:

US FDA completed inspection of Aarti Pharmalabs' Tarapur Unit-IV on 27 March 2026, issuing one procedural Form 483 observation; CAPA to be submitted within the regulatory timeline.

AI Assistant

Aarti Pharmalabs Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.